Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.82 USD
Change Today -0.18 / -2.57%
Volume 1.8M
As of 4:00 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary S. Jacob Ph.D.

Chairman, Chief Executive Officer and President,Synergy Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 29 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Gary S. Jacob, Ph.D. has been the Chairman, Chief Executive Officer and President of Synergy Pharmaceuticals, Inc. since September 2013 and since July 2008 respectively. Dr. Jacob served as the Chief Executive Officer of Callisto Pharmaceuticals Inc. since May 2003 until January 2013. He served as Secretary of TrovaGene, Inc. (Alternate Name: Xenomics, Inc.) since February 2009. Dr. Jacob served as the Chief Executive Officer and President of ContraVir Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-297-0020
Fax: 212-297-0019

Board Members Memberships*

Chairman, Chief Executive Officer and President
Independent Director and Member of Compensation Committee


University of Wisconsin - Madison
University of Missouri-Columbia

Other Affiliations*

Annual Compensation*

Total Annual Compensation$750,000

Stock Options*

Exercisable Options1,857,671
Unexercisable Options2,541,060
Total Number of Options4,398,731

Total Compensation*

Total Annual Cash Compensation$750,000
Total Short Term Compensation$750,000
Total Calculated Compensation$3,082,879
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGYP:US $6.82 USD -0.18


Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee
Almirall, S.A.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at